 |
 |
Therapeutic effect of repetitive transcranial magnetic stimulation in PD Shimamoto H, Morimitsu H, Sugita S, Nakahara K, Rinsho Shinkeigaku. 1999 Dec;39(12):1264-7. PMID: 10791094; UI: 20251690 Molecular mechanism of monoamine toxicity in PD Jimenez del Rio M, Velez-Pardo C. Med Hypotheses. 2000 Feb;54(2):269-74. PMID: 10790763; UI: 20253830 The toxic mind: the biology of mental illness and violence. Van Winkle E. Med Hypotheses. 2000 Jan;54(1):146-56. PMID: 10790741; UI: 20250365 New animal models for Parkinson's disease. Dawson TM. Cell. 2000 Apr 14;101(2):115-8. Review. No abstract available. PMID: 10786830; UI: 20246502 Pharmaceutical target discovery: PD and schizophrenia genes. Walker MG, Volkmuth W, Klingler TM. Ismb. 1999;:282-6. PMID: 10786311; UI: 20248035 Cardiovascular autonomic dysfunction in PD Mathias CJ. Clin Neurosci. 1998;5(2):153-66. Review. PMID: 10785842; UI: 20247548 Visuo-cognitive dysfunctions in PD Antal A, Bandini F, Keri S, Bodis-Wollner I. Clin Neurosci. 1998;5(2):147-52. Review. PMID: 10785841; UI: 20247547 Gastrointestinal dysfunction in PD Pfeiffer RF. Clin Neurosci. 1998;5(2):136-46. Review. PMID: 10785840; UI: 20247546 Respiratory function in PD Shill H, Stacy M. Clin Neurosci. 1998;5(2):131-5. Review. PMID: 10785839; UI: 20247545 Neurophysiology of sensorimotor integration in PD Rossini PM, Filippi MM, Vernieri F. Clin Neurosci. 1998;5(2):121-30. Review. PMID: 10785838; UI: 20247544 Imaging of nonmotor symptoms in Parkinson syndromes. Paulus W, Trenkwalder C. Clin Neurosci. 1998;5(2):115-20. Review. PMID: 10785837; UI: 20247543 Sleep dysfunction in PD Trenkwalder C. Clin Neurosci. 1998;5(2):107-14. Review. PMID: 10785836; UI: 20247542 Visual dysfunction in PD Rodnitzky RL. Clin Neurosci. 1998;5(2):102-6. Review. PMID: 10785835; UI: 20247541 Olfactory dysfunction in PD Wszolek ZK, Markopoulou K. Clin Neurosci. 1998;5(2):94-101. Review. PMID: 10785834; UI: 20247540 Behavioral dysfunction in PD Friedman JH. Clin Neurosci. 1998;5(2):87-93. Review. PMID: 10785833; UI: 20247539 Urinary dysfunction in PD Singer C. Clin Neurosci. 1998;5(2):78-86. Review. PMID: 10785832; UI: 20247538 Sexual dysfunction in PD Lambert D, Waters CH. Clin Neurosci. 1998;5(2):73-7. Review. PMID: 10785831; UI: 20247537 Pain in PD Ford B. Clin Neurosci. 1998;5(2):63-72. Review. PMID: 10785830; UI: 20247536 CP-101,606, an Antagonist of NR2B Subunit-Containing N-Methyl-d-Aspartate Receptors. Steece-Collier K, Chambers LK, Jaw-Tsai SS, Menniti FS, Exp Neurol. 2000 May;163(1):239-243. PMID: 10785463 125I-CGP 64213 Binding to GABA(B) Receptors in the Brain of Monkeys Calon F, Morissette M, Goulet M, Grondin R, Exp Neurol. 2000 May;163(1):191-199. PMID: 10785458 GDNF and NT-4 Protect Dopaminergic Neurons from Damage by Iron and Nitric Oxide. Lingor P, Unsicker K, Krieglstein K. Exp Neurol. 2000 May;163(1):55-62. PMID: 10785444 An Altered Histaminergic Innervation of the Substantia Nigra in PD Anichtchik OV, Rinne JO, Kalimo H, Panula P. Exp Neurol. 2000 May;163(1):20-30. PMID: 10785440 PD impairs the ability to change set quickly. Chong RK, Horak FB, Woollacott MH. J Neurol Sci. 2000 Apr 1;175(1):57-70. PMID: 10785258 Early differentiation of PD and MSA with I-123-MIBG-SPECT. Druschky A, Hilz MJ, Platsch G, Radespiel-Troger M, J Neurol Sci. 2000 Apr 1;175(1):3-12. PMID: 10785250 VIP relevance to neuroprotection in PD Offen D, Sherki Y, Melamed E, Fridkin M, Brain Res. 2000 Jan 31;854(1-2):257-62. PMID: 10784133; UI: 20244719 GDNF and increased survival of dopaminergic neurons in fetal grafts Espejo M, Cutillas B, Arenas TE, Ambrosio S. Cell Transplant. 2000 Jan-Feb;9(1):45-53. PMID: 10784066; UI: 20244652 Effect of swallowing training on swallowing disorders in PD Nagaya M, Kachi T, Yamada T. Scand J Rehabil Med. 2000 Mar;32(1):11-5. PMID: 10782935; UI: 20243029 Structural changes in substantia nigra in PD revealed by MR imaging. Hutchinson M, Raff U. AJNR Am J Neuroradiol. 2000 Apr;21(4):697-701. PMID: 10782780; UI: 20242874 Effects of L-DOPA and the D1 agonist SKF 82958 in monkey model. Andringa G, Lubbers L, Drukarch B, Stoof JC, Behav Pharmacol. 1999 Mar;10(2):175-82. PMID: 10780830; UI: 20241742 Effects of D2 agonist quinpirole and D1 agonist SKF 81297 in monkey model. Andringa G, Vermeulen RJ, Drukarch B, Renier WO, Behav Pharmacol. 1999 Mar;10(2):163-73. PMID: 10780829; UI: 20241741 COMT inhibition in PD: rationale and clinical relevance. Deleu D. Acta Neurol Belg. 2000 Mar;100(1):5-7. No abstract available. PMID: 10779856; UI: 20242128 Parkinsonian Motor Characteristics in Unipolar Major Depression. Rogers MA, Bradshaw JL, Phillips JG, Chiu E, J Clin Exp Neuropsychol. 2000 Apr;22(2):232-244. PMID: 10779837 Effect of selegiline on cognitive functions in PD Dixit SN, Behari M, Ahuja GK. J Assoc Physicians India. 1999 Aug;47(8):784-6. PMID: 10778622; UI: 20241090 Rejection of Porcine Mesencephalic Xenografts in a Rat Model of PD Barker RA, Ratcliffe E, McLaughlin M, Richards A, J Neurosci. 2000 May 1;20(9):3415-3424. PMID: 10777804 Sleep attacks and PD treatment. Ferreira JJ, Galitzky M, Montastruc JL, Rascol O. Lancet. 2000 Apr 15;355(9212):1333-4. PMID: 10776750; UI: 20236508 Sleep attacks (sleep episodes) with pergolide. Schapira AH. Lancet. 2000 Apr 15;355(9212):1332-3. PMID: 10776749; UI: 20236507 Abnormal reciprocal inhibition between antagonist muscles in PD Meunier S, Pol S, Houeto JL, Vidailhet M. Brain. 2000 May;123(Pt 5):1017-1026. PMID: 10775546 The surgical treatment of PD Follett KA. Annu Rev Med. 2000;51:135-47. PMID: 10774457; UI: 20236272 Repetitive transcranial magnetic stimulation in PD Siebner HR, Mentschel C, Auer C, Lehner C, Neurosci Lett. 2000 Apr 28;284(3):147-50. PMID: 10773420; UI: 20237803 Naloxone Protects Rat Dopaminergic Neurons against Inflammatory Damage Liu B, Du L, Hong JS. J Pharmacol Exp Ther. 2000 May 1;293(2):607-617. PMID: 10773035 Metabolic activity in the subthalamic nucleus in a rat model of PD Orieux G, Francois C, Feger J, Yelnik J, Neuroscience. 2000;97(1):79-88. PMID: 10771341; UI: 20235584 Nicotinic receptors and PD Quik M, Jeyarasasingam G. Eur J Pharmacol. 2000 Mar 30;393(1-3):223-30. PMID: 10771017; UI: 20235313 Functional brain imaging of movement disorders. Eidelberg D, Edwards C. Neurol Res. 2000 Apr;22(3):305-12. PMID: 10769825; UI: 20232658 Mechanisms of deep brain stimulation and future technical developments. Montgomery EB Jr, Baker KB. Neurol Res. 2000 Apr;22(3):259-66. PMID: 10769818; UI: 20232651 Advances in neurostimulation for movement disorders. Gross RE, Lozano AM. Neurol Res. 2000 Apr;22(3):247-58. PMID: 10769817; UI: 20232650 Future prospects of brain stimulation. Benabid AL, Koudsie A, Pollak P, Kahane P, Neurol Res. 2000 Apr;22(3):237-46. PMID: 10769816; UI: 20232649 Parkinson disease survival: a population-based study. Morgante L, Salemi G, Meneghini F, Di Rosa AE, Arch Neurol. 2000 Apr;57(4):507-12. PMID: 10768625; UI: 20229112 The alpha-synuclein gene and PD in a Chinese population. Chan DK, Mellick G, Cai H, Wang XL, Arch Neurol. 2000 Apr;57(4):501-3. PMID: 10768624; UI: 20229111 Cognitive impairment and the brain dopaminergic system in PD Rinne JO, Portin R, Ruottinen H, Nurmi E, Arch Neurol. 2000 Apr;57(4):470-5. PMID: 10768619; UI: 20229106 Subthalamic stimulation in PD: a multidisciplinary approach. Houeto JL, Damier P, Bejjani PB, Staedler C, Arch Neurol. 2000 Apr;57(4):461-5. PMID: 10768618; UI: 20229105 PET: the merging of biology and imaging into molecular imaging. Phelps ME. J Nucl Med. 2000 Apr;41(4):661-81. Review. PMID: 10768568; UI: 20229055 Binding of [99mTc]TRODAT-1 to dopamine transporters in PD Mozley PD, Schneider JS, Acton PD, Plossl K, J Nucl Med. 2000 Apr;41(4):584-9. PMID: 10768556; UI: 20229043 janet paterson 53 now / 41 dx / 37 onset 613 256 8340 / PO Box 171 Almonte Ontario K0A 1A0 Canada visit my website "a new voice" at: http://www.geocities.com/janet313/